Lori L. Davis, MD

The author discusses a recent analysis by Zimmerman and Snyder focusing on the generalizability of PTSD treatment trials.

In this 10-week study, brexpiprazole in combination with sertraline, but not as monotherapy, demonstrated the potential to be a new efficacious treatment for PTSD.

Dysregulation of noradrenergic activity plays a key role in symptom presentation in major depressive disorder, schizophrenia, Alzheimer’s agitation, and PTSD. This article provides an expert panel’s consensus regarding the...

Studies on the economic burden of posttraumatic stress disorder (PTSD) mostly focus on military populations and/or direct health care costs. This study estimated the economic burden of PTSD in...